Advertisement

Chromatographia

, Volume 69, Issue 7–8, pp 765–769 | Cite as

Development and Validation of Specific Stability Indicating CE Assay Method for HIV-Protease Inhibitor Indinavir Sulphate

Full Short Communication

Abstract

A capillary electrophoresis method has been optimized for the specific and stability indicating assay for indinavir sulphate, a HIV-protease inhibitor. The stress-degraded studies showed that the drug is susceptible to degrade in acidic, alkaline and neutral hydrolysis; and also in oxidation and thermal conditions. The separation of indinavir sulphate and their degradation products were tested under different electrophoretic conditions and finally, 25 mM phosphate buffer (pH 3.0) were optimized. The detection was performed at a UV wavelength of 196 nm. In the previously reported CE method for assay of indinavir sulphate, diazepam is used as an internal standard, which is susceptible to degrade under acidic pH condition. In this proposed method, imidazole has been used as an IS and is stable over acidic pH condition used in this experiment. The proposed CE method is also superior over the reported TLC method in terms of simplicity, cost and resolving the number of degradation products. The method was also validated and the recoveries of active ingredients in bulk drugs and formulations are greater than 99.55% with an RSD ≤1.23%. This is the first report on an ideal stability-indicating CE method that quantifies selectively indinavir sulphate in the presence of degradation products.

Keywords

Capillary electrophoresis Specific stability indicating assay HIV-protease inhibitor Indinavir sulphate 

Notes

Acknowledgments

The authors are grateful to Hetero Drugs Ltd for providing drug reference standards. Authors are also thankful to Dr. J.S. Yadav, Director, Indian Institute of Chemical Technology (IICT) for his permission and encouragement to pursue this research work.

References

  1. 1.
    International Conference on Harmonization (2003) IFPMA, GenevaGoogle Scholar
  2. 2.
    Eron JJ (2000) Clin Infect Dis 30:S160–S170. doi: 10.1086/313853 CrossRefGoogle Scholar
  3. 3.
    Acosta EP, Henry K, Baken L, Page LM, Fletcher CV (1999) Pharmacotherapy 19:708–712. doi: 10.1592/phco.19.9.708.31544 CrossRefGoogle Scholar
  4. 4.
    Burger DM, de Graff M, Wuis EW (1997) J Chromatogr B Analyt Technol Biomed Life Sci 703:235–241. doi: 10.1016/S0378-4347(97)00421-0 CrossRefGoogle Scholar
  5. 5.
    Jayewardene AL, Zhu F, Aweeka FT (1998) J Chromatogr B Analyt Technol Biomed Life Sci 707:203–211. doi: 10.1016/S0378-4347(97)00607-5 CrossRefGoogle Scholar
  6. 6.
    Foisy ML, Sommadossi JP (1999) J Chromatogr B Analyt Technol Biomed Life Sci 721:239–247. doi: 10.1016/S0378-4347(98)00451-4 CrossRefGoogle Scholar
  7. 7.
    Fizzano MR, Valvo L, Dupis ML (2000) J Pharm Biomed Anal 22:307–314. doi: 10.1016/S0731-7085(99)00288-5 CrossRefGoogle Scholar
  8. 8.
    Zhong L, Yeh KC (1999) J Chromatogr B Analyt Technol Biomed Life Sci 734:63–71. doi: 10.1016/S0378-4347(99)00342-4 CrossRefGoogle Scholar
  9. 9.
    Marzolini C, Telenti A, Buclin T (2000) J Chromatogr B Analyt Technol Biomed Life Sci 740:43–58. doi: 10.1016/S0378-4347(99)00573-3 CrossRefGoogle Scholar
  10. 10.
    Daily EE, Thomas L, Kergueris MF (2001) J Chromatogr B Analyt Technol Biomed Life Sci 758:129–135. doi: 10.1016/S0378-4347(01)00117-7 CrossRefGoogle Scholar
  11. 11.
    Langmann P, Klinker H, Schirmer D (1999) J Chromatogr B Analyt Technol Biomed Life Sci 735:41–50. doi: 10.1016/S0378-4347(99)00388-6 CrossRefGoogle Scholar
  12. 12.
    Yamada H, Kotaki H, Nakamura T (2001) J Chromatogr B Analyt Technol Biomed Life Sci 755:85–89. doi: 10.1016/S0378-4347(00)00617-4 CrossRefGoogle Scholar
  13. 13.
    Simon VA, Thiam MD (2001) J Chromatogr A 913:447–453. doi: 10.1016/S0021-9673(00)01092-X CrossRefGoogle Scholar
  14. 14.
    Ray J, Pang E, Carey D (2002) J Chromatogr B Analyt Technol Biomed Life Sci 775:225–230. doi: 10.1016/S1570-0232(02)00295-7 CrossRefGoogle Scholar
  15. 15.
    Metz P, Kohlhepp SJ, Gilbert DN (2002) J Chromatogr B Analyt Technol Biomed Life Sci 773:159–166. doi: 10.1016/S1570-0232(02)00140-X CrossRefGoogle Scholar
  16. 16.
    Turner ML, Walker KR, King JR (2003) J Chromatogr B Analyt Technol Biomed Life Sci 784:331–341. doi: 10.1016/S1570-0232(02)00822-X CrossRefGoogle Scholar
  17. 17.
    Chi J, Jayewardene AL, Stone JA (2002) J Pharm Biomed Anal 30:675–684. doi: 10.1016/S0731-7085(02)00357-6 CrossRefGoogle Scholar
  18. 18.
    Woolf EJ, Matuszewski BK (1998) J Pharm Biomed Anal 18:347–357. doi: 10.1016/S0731-7085(98)00048-X CrossRefGoogle Scholar
  19. 19.
    Jayewardene AL, Kearney B, Stone JA (2001) J Pharm Biomed Anal 25:309–317. doi: 10.1016/S0731-7085(00)00506-9 CrossRefGoogle Scholar
  20. 20.
    Rose MJ, Merschman SA, Eisenhandler R (2000) J Pharm Biomed Anal 24:291–305. doi: 10.1016/S0731-7085(00)00420-9 CrossRefGoogle Scholar
  21. 21.
    Kreuz DM, Howard AL, Ip D (1999) J Pharm Biomed Anal 19:725–735. doi: 10.1016/S0731-7085(98)00297-0 CrossRefGoogle Scholar
  22. 22.
    Jancic B, Medenica M, Ivanovic D, Malenovic A (2005) Chromatographia 62:233–238. doi: 10.1365/s10337-005-0617-5 CrossRefGoogle Scholar
  23. 23.
    Silva BC, Campos LMM, Nunan EA, Soares CDV, Silva GR, Ribeiro JA, Pianetti GA (2005) Quim Nova 28:50–53Google Scholar
  24. 24.
    Yekkaala R, Lei H, Hoogmartens J, Adams E (2006) J Pharm Biomed Anal 42:71–80. doi: 10.1016/j.jpba.2006.01.045 CrossRefGoogle Scholar
  25. 25.
    Kaul N, Agrawal H, Paradkar AR, Mahadik KR (2004) IL Farmaco 59:729–738. doi: 10.1016/j.farmac.2004.03.012 CrossRefGoogle Scholar
  26. 26.
    Aurora Prado MS, Kedor Hackmann ERM, Santoro MIRM, Pinto MFM, Tavaris TJA (2004) J Pharm Biomed Anal 34:441–450. doi: 10.1016/S0731-7085(03)00530-2 CrossRefGoogle Scholar
  27. 27.
    Sekar R, Azhaguvel S (2005) J Pharm Biomed Anal 39:653–660. doi: 10.1016/j.jpba.2005.05.002 CrossRefGoogle Scholar
  28. 28.
    International Conference on Harmonization (1996) Q2A Validation of Analytical Procedure, Methodology, GenevaGoogle Scholar
  29. 29.
    Bedair M, Koray MA, Hamid MBA (1984) Analyst (Lond) 109:1423–1426. doi: 10.1039/an9840901423 CrossRefGoogle Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2009

Authors and Affiliations

  1. 1.Analytical Chemistry DivisionIndian Institute of Chemical TechnologyHyderabadIndia

Personalised recommendations